B of A Securities Maintains Neutral on United Therapeutics, Raises Price Target to $463

Benzinga · 09/02/2025 17:46
B of A Securities analyst Greg Harrison maintains United Therapeutics (NASDAQ:UTHR) with a Neutral and raises the price target from $314 to $463.